CSII News and Press, Cardiovascular Systems Inc. From 08/02/22

Webcast Scheduled for Tomorrow, August 3, 2022, at 9:00 a.m. CT (10:00 a.m. ET) Revenues of $62.5 million increased 11% sequentially compared to third quarter this year and decreased 12% compared to fourth quarter last year Management provides fiscal 23 revenue guida...

ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model looks to “Grow Markets and Take Market Share” targeting an ...

AngioDynamics posted better sales growth in FQ4'22 as elective procedure counts continue to rebound, but margin pressures continue to weigh significantly. The company is building a sustainable core growth story, with multiple opportunities to gain share and grow addressable markets in...

Webcast of Capital Markets Day on August 3 will include discussion of fiscal fourth-quarter results Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will release fourth-quarter results the evening of August 2. In lieu of hosting a quarterly earnings conferen...

Cardiovascular Systems (NASDAQ:CSII) said on Tuesday its chief operating officer Rhonda Robb's employment with the company had ended on Monday. The company said in a form 8-K filing on Tuesday. The company said Robb will receive benefits consistent with the Company’s Exe...

Cardiovascular Systems, Inc. (CSII) Q3 2022 Earnings Conference Call May 5 2022 9:00 AM ET Company Participants Jack Nielsen - Vice President, Investor Relations Scott Ward - Chairman, President, and Chief Executive Officer Jeff Points - Chief Financial Officer Rhonda Robb - Chief Operating O...

The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Cardiovascular Systems, Inc. 2022 Q3 - Results - Earnings Call Presentation

Image source: The Motley Fool. Cardiovascular Systems (NASDAQ: CSII) Q3 2022 Earnings Call May 04, 2022 , 9:00 a.m. ET Operator Continue reading For further details see: Cardiovascular Systems (CSII) Q3 2022 Earnings Call Transcript

Cardiovascular Systems press release (NASDAQ:CSII): FQ3 GAAP EPS of -$0.25 beats by $0.03. Revenue of $56.22M (-11.1% Y/Y) misses by $1.16M. As of March 31, 2022, CSI had cash and marketable securities totaling $172.1 million and no long-term borrowings. For further details see: Cardiov...

Conference Call Scheduled for Today, May 4, 2022, at 8:00 a.m. CT (9:00 a.m. ET) Revenues of $56.2 million decreased 4.9% sequentially compared to second quarter this year and decreased 11.1% compared to third quarter last year Fiscal year 22 revenue guidance narrowe...